Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) was the target of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling 2,513 shares, an increase of 29.6% from the February 12th total of 1,939 shares. Based on an average daily trading volume, of 2,710 shares, the days-to-cover ratio is currently 0.9 days. Based on an average daily trading volume, of 2,710 shares, the days-to-cover ratio is currently 0.9 days.
Hikma Pharmaceuticals Stock Performance
HKMPY opened at $31.80 on Monday. The company’s 50-day simple moving average is $40.67 and its two-hundred day simple moving average is $43.23. Hikma Pharmaceuticals has a 52-week low of $31.80 and a 52-week high of $56.94.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Featured Articles
- Five stocks we like better than Hikma Pharmaceuticals
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s gold reserves are priced at $42. The real price is $6,000+.
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
